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A complete thermodynamic and kinetic solution study on lanthanide(III) complexes with monoacetamide (DOTAMA, L1) and 
monopropionamide (DOTAMAP, L2) derivatives of DOTA (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) was 
undertaken with the aim to elucidate their stability and inertness in aqueous media. The stability constants of GdL1 and GdL2 are 10 
comparable,  whereas a more marked difference is found in the kinetic inertness of the two complexes. The formation of the Eu(III) and 
Ce(III) complexes takes place via the formation of the protonated intermediates which can deprotonate and transform into the final 
complex through a OH- assisted pathway. GdL2 shows faster rates of acid catalysed decomplexation with respect to GdL1, which has a 
kinetic inertness comparable to GdDOTA. Nevertheless, GdL2 is one order of magnitude more inert than GdDO3A. A novel 
DOTAMAP-based bifunctional chelating ligand and its deoxycholic acid derivative (L5) were also synthesized. Since the coordinated 15 
water molecule in GdL2 is characterized by an exchange rate ca. two order of magnitude greater than in GdL1, the relaxivity of the 
macromolecular derivatives of GdL5 should not be limited by the slow water exchange process. The relaxometric properties of the 
supramolecular adduct of GdL5 with Human Serum Albumin (HSA) were investigated in aqueous solution by measuring the magnetic 
field dependence of the 1H relaxivity that, at 20 MHz and 298 K, shows a 430% increase over that of the unbound GdL5 chelate. Thus, 
Gd(III) complexes with DOTAMAP macrocyclic ligands can represent good candidates for the development of stable and highly 20 
effective bioconjugate systems for molecular imaging applications. 
Introduction 
Magnetic Resonance Imaging (MRI) has rapidly gained a 
position of prominence in diagnostic clinical medicine and 
biomedical research due to numerous favourable features:  non-25 
invasiveness, great spatial and temporal resolution, deep tissue 
penetration, excellent inherent soft tissue contrast, easy access to 
the detailed anatomical and functional information. The intrinsic 
contrast is further improved by the use of contrast agents (CAs) 
both in the clinical setting and in the preclinical research 30 
laboratories. The use of CAs allows adding further physiological 
information of great importance to the excellent anatomical 
resolution typically observed in the images acquired in MRI. 
Furthermore, CAs enable to decrease the time for image 
acquisition, improve the reliability of the diagnosis and reduce 35 
artefacts. Over the past two decades, the extensive utilization of 
Gd(III) complexes as MRI T1 shortening agents has also had a 
profound influence on the research in the field of lanthanide 
coordination chemistry. In fact, a primary goal in the 
development of Gd-based CAs is the improvement of the 40 
efficiency of the probes through optimization of the molecular 
parameters that control the magnetic coupling between the 
paramagnetic ion and water molecules. The efficiency is typically 
measured by the longitudinal proton relaxivity (r1, the increase in 
the water proton relaxation rate per mM concentration of Gd) 45 
that, for the clinically approved Gd(III) complexes, lies in the 
range 4−5 mM−1 s−1, at 20 MHz (0.47 T) and 298 K.1 The key 
molecular parameters that govern the relaxivity of a Gd(III) 
complex, according to the established theory of paramagnetic 
relaxation, are the number (q) and residence lifetime, τM, of the 50 
inner sphere water molecule(s) and the rotational motion of the 
paramagnetic system, described by the correlation time τR.
1  
Another fundamental issue in the development of CAs, 
increasingly important in recent years, is related to the stability of 
the MRI probes with respect to the potential release of toxic 55 
gadolinium ions in vivo. It has been long recognized that, for a 
safe in vivo use, Gd(III) ion needs be encapsulated into a chelate 
characterized by high thermodynamic stability and kinetic 
inertness.2 This is typically achieved with octadentate 
polyaminocarboxylate chelators mainly based on two structural 60 
motifs: the macrocyclic 1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetic acid (DOTA) and the acyclic diethylenetriamine 
pentaacetic acid (DTPA). In particular, high in vivo stability is 
required when the probe is used for targeting procedures or in 
other cases that involve a slow excretion (i.e. impaired kidney 65 
function) so that the longer residence time is associated with a 
greater risk of dissociation. In fact, it has been recently reported 
that the release of Gd(III) ions from MRI probes based on acyclic 
ligands in patients with renal failure is related to the occurrence 
of Nephrogenic Systemic Fibrosis (NSF), a very rare but severe 70 
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disease.3-6 Metal ion dissociation was not observed with 
macrocyclic chelates and several studies both in vitro and in vivo, 
in mice and in humans, consistently demonstrated that kinetic 
inertness of macrocyclic Gd(III) complexes is superior to that of 
acyclic ones.5-10 Based on these results, Gd-chelates with 5 
derivatives of DOTA are considered the most kinetically inert 
and are therefore most suitable for in vivo applications. A class of 
compounds of particular importance is represented by the DOTA 
monoamide derivatives that allow obtaining complexes 
kinetically inert and electrically neutral. Since an initial report on 10 
the high values of the formation constant,11 a large number of 
DOTA monoamide derivatives have been synthesized and 
characterized for stable complexation of lanthanide cations.1, 12-16  
Typically, GdDOTA-like chelates present only one inner sphere 
water molecule (q = 1) and their relaxivity can be enhanced by 15 
increasing the molecular size, i.e. by conjugating the 
paramagnetic complexes to a variety of macromolecular 
substrates, and, hence, by slowing down the rotational tumbling 
rate (1/τR). For example, the reversible formation of host-guest 
adducts between suitably functionalized Gd(III) complexes and 20 
human serum albumin (HSA) represents one of the first strategies 
used to achieve large relaxation enhancements.17 However, it has 
been understood earlier that if the water exchange rate (kex = 
1/τM) is not sufficiently fast (≥ 5 × 10
7 s-1) the expected increase 
of r1 for Gd-based macromolecular systems is severely limited.
18 25 
To highlight the key role of a short τM, we have recently reported 
a preliminary study which compares the relaxometric behavior of 
two GdDOTA monoamide complexes (GdL1 and GdL2 in 
Scheme 1) and of the micellar aggregates formed by their 
amphiphilic derivatives bearing a stearoyl chain.19 In particular, 30 
we have shown that increasing the length of the carboxyamide 
arm from acetic (DOTA-monoacetamide = DOTAMA) to 
propionic (DOTA-monopropionamide = DOTAMAP) accelerates 
kex by nearly two orders of magnitude. In turn, this translates into  
r1 enhancements of the lipid aggregates, at 0.47 T, from +130% at 35 
278 K to +22% at 310 K. Such an increase in kex for 
GdDOTAMAP was attributed to a greater steric compression at 
the water coordination site, which induces an acceleration of the 
dissociatively activated exchange process, in agreement with 
previous findings of Éva Tóth and coworkers.20 Similar results 40 
for DOTA monopropionate derivatives, structurally related but 
featuring a net negative charge, have been recently reported.21-23 
Since the substitution of an acetamide by a propionamide might 
be accompanied by an undesired decrease of the thermodynamic 
stability and of the kinetic inertness, a complete thermodynamic 45 
and kinetic solution study on lanthanide complexes with the two 
ligands has been undertaken. In the previous work only the 
stability constants of GdL1 and GdL2 (logK = 20.86 and 20.22, 
respectively) were measured.13 Curiously enough, although 
DOTAMA-like ligands have been widely used in the literature, 50 
only a very limited number of thermodynamic solution date have 
been reported24, 25 and no kinetic studies have been published so 
far. Moreover, in order to highlight further the efficacy of the 
GdDOTAMAP-like chelates to enhance r1 of macromolecular 
probes, a novel DOTAMAP-based bifunctional chelating ligand 55 
and its deoxycholic acid derivative (L5) were synthesized. 
This targeting synthon has a strong affinity for HSA and has been 
used in the literature conjugated to Gd-chelates as hepatospecific 
or Dynamic Contrast Enhanced (DCE) MRI contrast agents.26, 27 
For instance, a DTPA-like contrast agent showing high biliary 60 
excretion and a great potential for hepatobiliary imaging was 
reported some years ago.28 Finally, the relaxometric properties of 
GdL5 and its supramolecular adduct with HSA were investigated 
in aqueous solution by measuring the magnetic field dependence 
of the 1H relaxivity. 65 
  
 
 
 
 70 
 
 
 
 
 75 
 
 
 
 
 80 
 
 
 
 
Scheme 1. The structure of the ligands discussed in the text. 85 
Results and Discussion 
Solution equilibrium studies. 
The replacement of one negatively charged carboxylate group of 
DOTA with a neutral amide group is known to significantly 
reduce the overall affinity of the ligand for the Ln3+-ions. Hence, 90 
the stability constants (logKLnL) of LnDOTA-monoamide 
complexes are typically 3 - 4 orders of magnitude lower than 
those of the LnDOTA-like complexes. A comparison of logKGdL 
values between GdL1 and GdL2 was reported in a preliminary 
communication; here, we present the results of a more detailed 95 
and thorough investigation on the solution properties of the 
Ln(III) complexes of L1 and L2 in order to clarify the effects of 
the increased length of the amide pendant arm on the equilibrium 
properties of the Ln(III)-complexes. 
Protonation equilibria: The protonation constants of H3L1 and 100 
H3L2 (logKi
H, i = 1, 2…6), defined by Equation (1), were 
determined by pH-potentiometry and are listed in Table 1 where 
are compared with those of H4DOTA, H3DO3A, and two 
H3DOTA-monoamide ligands (L3 and L4). 
 105 
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The protonation scheme of DOTA-like ligands is well known and 
it has been fully characterized with both spectroscopic and 
potentiometric methods.29-31 Thus, we may safely assume that the 5 
first and second protonation processes occur at two opposite ring 
nitrogen atoms, whereas the third and fourth protonation steps 
take place at the carboxylate groups of the acetic arms attached to 
the non-protonated ring nitrogen atoms, because of the greater 
charge separation and lower electrostatic repulsion between the 10 
protonated donor atoms.29   
Table 1. Protonation constants of H3L1, H3L2, H3DOTAMA-ethyl 
(H3L3) and H3DOTAMA-propyl (H3L4), H3DO3A and H4DOTA (0.1 M 
KCl, 298K). Standard deviations are shown in parentheses. 
 H3L1 H3L2 H3L3
a H3L4
 b H3DO3A
c H4DOTA
c 
logK1
H 11.77(2) 11.00 (3) 9.6 10.17 11.99 11.41 
logK2
H 9.98 (1) 9.52 (2) 9.2 9.02 9.51 9.83 
logK3
H 9.33 (1) 8.98 (4) 4.4 4.41 4.30 4.38 
logK4
H 4.01 (1) 4.59 (5) 1.7 2.94 3.63 4.63 
logK5
H 1.99 (1) 3.12 (5)  1.99 1.84 1.92 
logK6
H 1.53 (3) 1.88 (5)    1.58 
 35.09 34.09 24.9 26.54 29.43 30.25 
a Ref. [24] in NaCl (0.1 M), b Ref. [25] in KCl (1.0 M), c Ref. [30] in KCl 15 
(0.1 M) 
 
A comparison of protonation constants of L1 and L2 with those 
of DOTA and DO3A (Table 1) indicates that logK1
H and logK2
H 
values are substantially comparable, whereas the logK3
H values 20 
for L1 and L2 are nearly five orders of magnitude higher than for 
DOTA and DO3A. By considering the protonation constants of 
-alaninamide (logK1
H=9.32),32 we can make the reasonable 
assumption that the third protonation for L1 and L2 involves the 
nitrogen atom of the pendant amino group. Finally, logK4
H, 25 
logK5
H and logK6
H, corresponding to the protonation of three 
carboxylate groups, have similar values to those of DO3A and 
DOTA. It is worth noting that the logK1
H value of L1 and L2 is 
higher than that of the two DOTA-monoamide ligands, L3 and 
L4. A possible explanation concerns the different ionic strength 30 
used in the equilibrium studies of L3 and L4 (Table 1): the 
formation of weak Na+- and K+-complexes competing with the 
first protonation process may be responsible of the lower value of 
the protonation constant. Similar effects were observed for a 
number of DOTA and DO3A derivatives.33 35 
The total basicity (        ) of L1 and L2 is higher than that of 
DOTA and DO3A because of the relatively high protonation 
constant of the terminal amine nitrogen atom (Table 1). However, 
not considering the logKH value for the protonation of the 
terminal amino group, we obtain the                values of 27.75 and 40 
28.23 for L1 and L2, respectively. These values are significantly 
lower than for DOTA and comparable to that of DO3A. It follows 
that the thermodynamic stability of the lanthanide(III) complexes 
of L1 and L2 should be lower than that for the DOTA complexes 
and comparable to the DO3A complexes. Since the coordination 45 
of the amide oxygen of L1 and L2 to the metal ion results in the 
formation of five- and six-membered chelate rings, respectively, 
significant differences in their interaction with Ln3+ ions are 
expected.
Complexation properties: Often, the complex formation 50 
equilibria between macrocyclic ligands and Ln3+ ions cannot be 
studied by direct pH potentiometric titration because of the slow 
formation kinetics.34-42 Thus, the stability and protonation 
constants of LnL1,  GdL2 and LnDO3A complexes, defined by 
Eqn. (2) and (3), were investigated by pH-potentiometriy and by 55 
UV-spectrophotometry (Ce3+ - L1 system) using the “out of cell” 
procedure (298K, 0.1 M KCl) (Table 2). The UV-absorption 
spectra of the Ce3+ - L1 system used for the calculation of 
logKCeL value are reported in Figure S1. 
                                            60 
            (2) 
        
     i=1,2       (3) 
 
Table 2. Stability (logKLnL) and protonation constants (logKLnHiL) of 65 
LnL1, GdL2, LnL3 and LnL4, LnDO3A and LnDOTA complexes (0.1 
M KCl, 298K) 
 H3L1 H3L2 H3L3
a H3L4
 b H3DO3A
c H4DOTA
e 
LaL 20.49 (8)    18.63 21.7 
LaHL 9.10 (4)      
CeL 21.24 (5)   19.26 19.7 d 23.39 
CeHL 8.84 (7)   2.65   
GdL 22.25 (4) 20.22 (3) 20.1 21.29 21.56 24.7, 25.3f 
GdHL 9.24 (2) 8.40 (6)  2.57   
LuL 21.95 (7)   21.83 21.44 25.4 
LuHL 8.90 (4)   2.33   
a Ref. [24] in NaCl (0.1 M), b Ref. [25] in KCl (1.0 M), c Ref. [30] in KCl 
(0.1 M) d Ref. [43] in (Me)4NCl (0.1 M), 
e Ref. [44] in NaCl (0.1 M), f 
Ref. [45] in (Me)4NCl (0.1 M). 70 
 
As previously observed for the LnDO3A and LnDOTA 
complexes, the stability constants of LnL1 chelates increase 
moving from La(III) to Gd(III), while remaining almost constant 
for the  heavier members of the series (Table 2).2 The stability 75 
constants of the LnL1 complexes (Ln = La, Ce, Gd, Lu) are 
higher than those for the corresponding LnDO3A complexes and 
lower than those of the LnDOTA chelates, indicating not only 
that the amide group is involved in the coordination of the Ln(III) 
ions but also that it is a weaker donor than the carboxylate group. 80 
Interestingly, the stability constants for the LnL1 complexes are 
sensibly higher than those of the related DOTA monoamide 
derivatives LnL3 (Ln = Gd) and LnL4 (Ln = Ce, Gd, Lu). Such 
an effect is necessarily related to the presence of the terminal 
amino group and results in a stabilization particularly pronounced 85 
for the early members of the lanthanide series. The smaller value 
of the stability constant of GdL2 than for GdL1 and GdDO3A 
may be accounted for by both the lower value of the first 
protonation constant of L2 and by the weaker interaction between 
the amide O-atom and Gd3+ ion associated with the formation of a 90 
less stable six-membered chelate ring. However, it should be 
noted that the thermodynamic stability of GdL2 is quite 
comparable to GdL3 and GdL4, featuring an acetamide arm. 
Therefore, it can be concluded that the introduction of a 
propionamide group in place of an acetamide group in DOTA-95 
monoamide ligands has a pronounced effect on the kinetics of 
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water exchange of the corresponding Gd(III) complexes without 
clearly affecting their stability. The stability constant of GdL1 
differs slightly from the value previously reported 
(logKGdL1=20.86)
19 as a result of a new, more accurate 
determination. Finally, the protonation constants of the amino 5 
group in the LnL1 and GdL2 complexes (Table 2) are 
comparable with the third protonation constant of the free ligands 
(logK3
H), as expected for a pendant moiety not involved in the 
coordination of the lanthanide(III) cation. 
Complex formation kinetics  10 
The complex formation reactions L1 and L2 with Ln(III) ions 
were found to be slow in the pH range 3.5 – 6.5 where the 
protonated Ln(HL1) and Ln(HL2) species are predominant 
(Figure S2). It is well recognized that the formation reaction of 
macrocyclic Ln(III) complexes is generally slow,30, 34, 40, 41, 43, 46 15 
as a result of both the difficult encapsulation of the Ln3+ ions in 
the rigid and preformed coordination cage of DOTA-like ligands 
and the formation of stable protonated intermediates (*Ln(HxL)). 
The formation and  structure of the intermediates were 
investigated by spectrophotometry,34, 37 1H-NMR38 and 20 
luminescence spectroscopies.35, 36 The luminescence lifetime 
determination of the diprotonated intermediate *Eu(H2DOTA) 
indicates the presence of four or five H2O molecules in the inner 
coordination sphere of the metal ion, suggesting an out-of-cage 
coordination of Eu(III) by four carboxylate groups and the 25 
occurrence of two protonated diametrically opposed nitrogen 
atoms in the tetraaza cycle.35, 36 According to detailed kinetic 
studies,34-37, 39-41 the complexation process proceeds through two 
steps, the first of which involves the rapid formation of the 
diprotonated intermediate *Ln(H2DOTA)  which is in 30 
equilibrium with the monoprotonated species *Ln(HDOTA). In 
the second rate-determining step, the slow and OH- assisted 
deprotonation takes place, followed by the displacement of the 
metal ion into the cavity and rearrangement to the final complex 
LnDOTA.  35 
The rates of the formation reactions of Ce(III)- and Eu(III)-
complexes with L1 and L2 were studied by spectrophotometry in 
the presence of 5 - 40 folds excess of the Ln3+ ion in the pH range 
3.5 - 6.0. The absorption spectra of the Ce3+-L1, Eu3+-L1, Ce3+-
L2 and Eu3+-L2 reacting systems as a function of time are 40 
reported in Figures S3 and S4. From the kinetic data we obtain 
the pseudo first-order constants kobs that, plotted as a function of 
the Ln(III) concentration, yield saturation curves  indicating the 
fast formation of reaction intermediates (Figures S5 and S6). The 
first reaction step can be accounted for by the rapid formation of 45 
a tri-protonated intermediate (*Ln(H3L)) in which three 
carboxylate groups are coordinated to the Ln3+ ion and two 
opposite tertiary nitrogen atoms of the macrocycle and the amino 
group are protonated. The rate-determining step of the formation 
of the Ln(HL1) and Ln(HL2) species is the deprotonation of a 50 
ring nitrogen atom of  the *Ln(H2L1) and *Ln(H2L2) 
intermediates and the rearrangement to the final complexes. The 
proposed mechanism for the formation of Ln(HL1) and Ln(HL2) 
is reported in Scheme 2. The definitions and equations used for 
the evaluation of the kinetic data are reported in the Supporting 55 
Information. 
 
 
 
 60 
 
 
 
 
Scheme 2. The suggested pathway for the formation of Ln(HL1) and 65 
Ln(HL2). 
In Scheme 2, *KcLn(H3L), 
*KHLn(H2L), and kf are the conditional 
stability constants of *Ln(H3L1-2), the protonation constant of 
*Ln(H2L1-2) and the rate constant characterizing the 
deprotonation and structural rearrangement of the intermediates 70 
to the Ln(HL1) and Ln(HL2) complexes. The calculated *KcLn(H3L) 
values of *Ce(H3L) and *Eu(H3L) are 3.24(2) and 3.15(2) for L1 
and 2.80(2) and 2.98(4) for L2, respectively. These values are 
comparable with the conditional stability constant of the 
diprotonated *Gd(H2DO3A) intermediate (3.48)
39 and lower than 75 
those reported for the *Ln(H2DOTA) and *Ln(H2DO3A-Nprop) 
intermediates (*Ce(H2DOTA): 4.4, *Eu(H2DOTA): 4.3; 
*Ce(H2DO3A-Nprop): 4.51, *Gd(H2DO3A-Nprop): 4.50).
34, 46 
According to the *KcLn(H3L) values obtained, one can reasonably 
assume that the coordination sphere in *Ln(H3L1) and 80 
*Ln(H3L2) is similar to that of *Ln(H2DO3A). Moreover, the 
slightly higher conditional stability constants of *Ln(H3L1) as 
compared to *Ln(H3L2) may be explained by the stronger 
coordination of the acetamide O-atom of L1.  The rate constants 
kf for the formation of CeL and EuL (L = L1 and L2) as a 85 
function of the OH- concentration are shown in Figure 1. All kf 
rate constants show a first-order dependence on [OH-], expressed 
by Eq. (4), 
kf = kOH[OH
-]                                  (4) 
 90 
that is typical for the formation LnDOTA-like complexes, where 
kOH characterizes the OH
- assisted deprotonation of the 
protonated intermediates and the rearrangement to the final 
product.34-39, 41  
 95 
 
 
 
 
 100 
 
 
 
 
 105 
 
Figure 1. The kf rate constants for the formation reactions of the Ln(HL1) 
(A) and Ln(HL2) (B) complexes of Ce(III) (green triangle) and Eu(III) 
(blue diamond) as a function of [OH-]  (0.1 M KCl, 298K). 
The kOH rate constants were calculated by fitting the kf values 110 
(Figure 1) to Eqn. (4) (Tables 3). For L1 and L2, these values are 
comparable with those of LnDOTA and LnDO3A which 
indicates that the replacement of a carboxylic group with a 
carboxyamide does not alter the formation rate of the Ln(III) 
complexes. 115 
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Table 3. The kOH (M
-1s-1) rate constants characterizing the formation of 
L1, L2, DOTA, DO3A-Nprop, BT-DO3A and DO3A complexes with 
Ce(III) and Eu(III) (0.1 M KCl, 298K). 
 L13- L23- DOTA4- a DO3A-Npropb BT-DO3A c DO3A3- d 
Ce(III) 
(10-5) 
9.7 (1) 27 (1) 35 170 21  
Eu(III) 
(10-7) 
1.2 (1)  2.8 (1) 1.1 2.9 (Gd(III)) 0.48 2.1 (Gd(III)) 
a Ref. [34], b Ref. [46], c Ref. [41], d Ref. [39] 
 5 
Dissociation kinetics  
The kinetic inertness of lanthanide complexes represents a key 
requisite for their in vivo applications since the products of the 
dissociation reactions, both free Ln3+ ions and ligands, are toxic 
for living systems. The dissociation of LnDOTA-like complexes 10 
is very slow and generally proceeds through a proton-assisted 
pathway without the involvement of endogenous metal ions like 
Zn(II) and Cu(II).33, 34, 47, 48 To obtain information about the 
kinetic inertness of the Gd(III) complexes, the dissociation 
reactions of GdL1 and GdL2 were investigated in the presence of 15 
a large excess of H+ ([HCl]=0.05 – 1.0 M)  in order to ensure the 
occurrence of pseudo-first order conditions. These reactions were 
monitored by 1H-NMR relaxometry at 20 MHz and 298 K. The 
relaxivity values of GdL1 and GdL2 in 0.95 M HCl as a function 
of time are shown in Figure S7. Considering the relatively high 20 
protonation constant of the aminoethyl group in GdL1 and GdL2 
(logKGdHL=9.24 and 8.40, respectively; Table 2), the dissociation 
reactions is very likely to proceed via decomplexation of the 
monoprotonated Gd(HL) complexes. The proposed mechanism 
for the dissociation of GdL1 and GdL2 is shown in Scheme 3, 25 
whereas the definitions and equations used for the evaluation of 
the kinetic data are reported in the Supporting Information. 
 
 
 30 
 
 
 
 
Scheme 3. Proposed reaction pathways for the dissociation of the 35 
protonated complexes Gd(HL1) and Gd(HL2). 
In Table 4, the rate constants and the protonation constants 
characterizing the dissociation reactions of Gd(HL1) and 
Gd(HL2) are compared with the corresponding values for 
GdDOTA and GdDO3A. The half-lives (t1/2) of dissociation of 40 
Gd(III) complexes calculated at pH=7.4 are also reported. 
The values of the k0 rate constant describing the spontaneous 
dissociation of Gd(HL1) and Gd(HL2) are extremely low and 
characterized by large errors, to indicate the irrelevance of the 
spontaneous dissociation for the monoprotonated complexes. The 45 
k1 and k2 values, the proton assisted dissociation rate constants, 
differ considerably between the Gd(III) complexes of L1 and L2. 
The k1 value of Gd(HL1) is comparable with that of GdDOTA 
and 4 orders of magnitude smaller than that of GdDO3A, due to 
the particularly strong coordination of the amide oxygen atom. 50 
On the other hand, Gd(HL2) shows a k1 value almost three order 
of magnitude higher than that of Gd(HL1), being thus 
significantly more labile than Gd(HL1) and GdDOTA. 
Nevertheless, Gd(HL2) is significantly more inert than GdDO3A 
due to the coordination of the propionamide pendant arm. It is 55 
worth to make a comparison of k1 values of Gd(HL2) with 
Ce(DO3A-Nprop),46 since DO3A-Nprop ligand contain a 
propionate pendant arm and thus, like in Gd(HL2), it forms a six-
membered chelate ring upon lanthanide ion coordination. Hence, 
since the k1 values are almost comparable, it can be assumed that 60 
the interaction between the Ln3+ ion and the amide or the 
carboxylate oxygen atom of propionate pendant arms are very 
similar. The proton assisted dissociation of Gd(HL1) and 
Gd(HL2) proceeds through the protonation of the complexes at a 
carboxylate group. However, the resulting protonated complex is 65 
not reactive, since the protonation/deprotonation step of a 
carboxylate group is fast and the COO- group can coordinate 
again. Thus, dissociation is more likely to occur by proton 
transfer from the carboxylic acid to the N-atom of the ring, 
resulting in a relatively labile protonated intermediate. In such 70 
intermediate, the proton displaces the Gd3+ ion from the 
coordination cage, thereby causing the dissociation of the GdL 
complex. The protonation constants (KHGdH2L) of Gd(HL1) and 
Gd(HL2) (Table 4) are relatively small and comparable to the 
KHGdHL value of GdDOTA,
34 which indicates that the protonation 75 
is likely to take place at the carboxylate group. Finally, the t1/2 
values of Gd(HL1) and Gd(HL2) are an additional proof that the 
kinetic inertness of both Gd(III)-complexes is superior than that 
of GdDO3A (Table 4). In conclusions, these data suggest that 
both LnL1 and LnL2 could represent good platforms for the 80 
development of LnDOTA-like bioconjugate systems for 
molecular imaging applications.  
 
Table 4. Rate and equilibrium constants and half-lives (t1/2=ln2/kd, 
pH=7.4) for the dissociation reactions of Gd(HL1), Gd(HL2) GdDO3A 85 
and  GdDOTA complexes (298 K). 
 
Gd(HL1) Gd(HL2) 
Ce(DO3A-
Nprop)a 
Gd(DOTA)b Gd(DO3A)d 
I 
1.0 M 
KCl 
1.0 M 
KCl 
0.1 M     
KCl 
0.15 M     
NaCl 
0.1 M     
KCl 
k0 (s
-1)    6.7410-11  
k1            
(M-1s-1) 
(2.60.2) 
10-6 
(2.10.2) 
10-3 
710-3 1.8310-6 2.310-2 
k2            
(M-1s-1) 
(3.10.4) 
10-5 
(3.50.3) 
10-2 
0.51   
H
GdHLK  
1.7109  
(pH-pot) 
2.5108     
(pH-pot) 
260 14 c 115 e 
H
LGdH2
K
 
3.1  0.5 15  3 0.74   
kd (s
-1) 
pH=7.4 
1.010-13 8.410-11 2.810-10 7.310-14 9.210-10 
t1/2 (h) 
pH=7.4 
1.9109 2.3106 6.9105 2.6109 2.1105 
  a Ref. [46], b Ref. [47],  c Ref. [34],  d Ref. [30],  e Ref. [39] 
 
Synthesis of GdDOTAMAP-cholic acid (L5) 
To be able to interact strongly with macromolecular substrates 90 
thus achieving high relaxivities, a GdDOTAMAP-like chelate 
needs to be designed with a suitable targeting moiety linked to 
the coordination cage by a short spacer as little flexible as 
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possible. For these reasons, we synthesized a novel DOTAMAP-
based bifunctional chelator bearing a short spacer terminating 
with a free carboxylic acid (2 in Scheme 4) that can be covalently 
bound to specific biological carriers bearing a functionalizable 
amino group. In our case the DOTAMAP moiety was linked to a 5 
bile acid, known to strongly bind to the plasma protein and so to 
increase the circulation lifetime of the probe.26 
The synthesis of L5 (Scheme 4) started by the formation of 
benzyl 2-(acrylamido)acetate via acylation with acriloyl chloride 
under Schotten–Baumann conditions in a biphasic mixture of 10 
dichloromethane and aqueous potassium carbonate. Then, the 
alkylation of tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7-
triacetate (DO3A(OtBu)3) was accomplished via Michael 
addition of benzyl 2-(acrylamido)acetate followed by Pd/C 
catalysed hydrogenation of the benzyl ester to get the bifunctional 15 
chelator 2.  
 
 
 
 20 
 
 
 
 
 25 
 
 
 
 
 30 
 
Scheme 4. Synthesis of DOTAMAP-cholic acid (L5): i) CH2Cl2, 
K2CO3/H2O; ii) DO3A(tBu)3, CH3CN, N,N-diisopropylethylamine 
(DIPEA); iii) H2, Pd/C, MeOH; iv) aminodeoxycholic acid ethyl ester, 
DMF, 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-35 
b]pyridinium 3-oxid hexafluorophosphate (HATU), DIPEA; v) LiOH, 
MeOH; vi) TFA, CH2Cl2. 
The latter was reacted with (3,5,12)-3-amino-12-
hydroxycholan-24-oic acid methyl ester to obtain the fully 
protected ligand 3. At this stage, the methyl ester was hydrolyzed 40 
using LiOH in MeOH and finally, the deprotected ligand L5 was 
obtained as analytically pure white solids by precipitation with 
diethyl ether after hydrolysis of the t-butyl esters with TFA. 
The Gd(III) complex was synthesized by adding small volumes 
of a stock solution of GdCl3 to a solution of the ligand, 45 
maintaining the pH at 6.5 with diluted NaOH. The complexation 
process was monitored by measuring the change in the 
longitudinal water proton relaxation rate (R1) at 20 MHz and 298 
K (pH = 6.5) as a function of the concentration of Gd(III). 
Relaxometric characterization and HSA interaction 50 
The longitudinal relaxivity of GdL5 at 20 MHz and 310 K is 6.6 
mM-1s-1, consistent with the presence of one metal bound water 
molecule and in agreement with the r1 values measured under 
identical experimental conditions for related q=1 Gd-chelates of 
similar molecular weight. For instance, derivatives of GdDOTA 55 
and GdDTPA conjugated to cholic acid functionalities, such as a 
GdDTPA-cholic (r1 = 6.4 mM
-1 s-1)27 and a GdDOTA-cholic (r1 ~ 
5 mM-1s-1).49 Only the recently reported Gd(III) complex with a 
deoxycholic acid derivative linked to the AAZTA chelator 
(AAZTA = 6-amino-6-methylperhydro-1,4-diazepine tetraacetic 60 
acid) resulted in a higher r1 value as a result of the presence of 
two inner-sphere water molecules.27 
Detailed information about the molecular parameters determining 
the relaxometric behaviour of Gd(III) complexes can be gained 
by recording and analysing the Nuclear Magnetic Relaxation 65 
Dispersion (1H NMRD) profiles. This magnetic field dependence 
of the 1H r1 was measured, at 298 and 310 K, in the frequency 
range 0.01-70 MHz, corresponding to magnetic field strengths 
varying between 2.34 × 10-4 and 1.64 T (Figure 2). The profiles 
show the typical shape for low molecular weight complexes, with 70 
a region of constant r1 at low fields, a dispersion around 2-5 MHz 
and another plateau at higher frequencies (> 10 MHz). The lower 
values of the relaxivity at 310 K over the entire range of 
frequencies proton Larmor confirm that r1 is not limited by the 
change of water, but rather by the fast rotational motion of the 75 
complex. The experimental data were then analysed by a least-
square fitting procedure to the established theory for 
paramagnetic relaxation, using the well-known Solomon–
Bloembergen–Morgan (SBM) equations and Freed’s model for 
the inner- and outer-sphere contributions to the proton relaxivity, 80 
respectively.1 Some of the parameters involved in the description 
of the magnetic field dependence of r1 can be fixed to standard 
values, typical of GdDOTA-like chelates. In particular, the 
number of coordinated water molecules (q) was fixed to one; the 
distance of closest approach of the outer-sphere water molecules 85 
to Gd3+ was set to 4.0 Å; the relative diffusion coefficient (D) was 
fixed to 2.24 × 10-5 cm2 s-1 (298 K) and to the Gd–water proton 
distance (rGd–H) was attributed the value of 3.0 Å. In addition, for 
the exchange lifetime we used the same value previously 
determined for GdL2, i.e., 298M = 12 ns. We then used 
2, V, 90 
and R as adjustable parameters and obtained the results reported 
in Table 5. The rotational correlation time R is more than two 
times longer than for GdL2 and this simply reflect the increased 
molecular weight (slower tumbling) of the cholic acid derivative. 
The parameters associated with the electronic relaxation, 2 and 95 
V, assume values quite comparable to those found for GdL2, 
which is a further evidence of a strictly similar coordination cage. 
Table 5. Best-fit parameters obtained by analysis of the 1H NMRD 
profiles for GdL5 and for the GdL5/HSA adduct compared to parent 
GdL2 chelate.a 100 
 a For the parameters q, a and 298D the values of 1, 4.0 Å, 2.2410−5 cm2 
s−1, respectively, were used. b Ref. [19]. * Values fixed during the fitting 
Parameters GdL5 GdL5-HSA GdL2b GdL1b 
2 /×1019 s-2 3.2 ± 0.1 0.8 ± 0.1 3.9 3.8 
298V / ps 21.3 ± 0.4 54.4 ± 0.2 15 11 
298kex /×10
6 s-1 81.2b 81.2b 81.2 1.1 
298RG / ns 0.20 ± 0.01 40 ± 5 0.079 0.079 
298RL / ns --- 0.64 ± 0.02 --- --- 
rGd–H / Å 3.00
* 3.00* 3.00* 3.00* 
S2 --- 0.37 ± 0.01 --- --- 
NN
N N
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Figure 2. Left: 1H NMRD profiles of GdL5 (empty circles) and of 
GdL5/HSA adduct in the presence of 10 fold excess of HSA (filled 
squares) at 298 K. Right: water proton relaxation rate of a 0.1 mM 
aqueous solution of GdL5 as a function of HSA concentration (20 MHz, 
298 K).  5 
 
As mentioned above, deoxycholic acid is known to form host-
guest adducts with HSA with high association constants. Since 
HSA is a protein of 66.437 Da, its reversible interaction with a 
functionalized Gd complex induces an increase of the 10 
reorientational correlation time R of the paramagnetic system 
and hence marked relaxivity enhancements. The formation of the 
adduct between GdL5 and HSA was investigated through the 
well-established 1H proton relaxation enhancement (PRE) 
technique. This consists in measuring the variation in the 15 
longitudinal relaxation rate, R1, of a dilute solution of the 
paramagnetic guest for increasing concentrations of the host. 
With this method, the binding parameters KA, n (the number of 
equivalent and independent binding sites), and r1
b (the relaxivity 
of the resulting supramolecular adducts) can be assessed. To this 20 
end, a 0.1 mM solution of GdL5 was titrated with HSA, at 20 
MHz and 298 K, and the least-squares fit of plot of R1 versus 
HSA concentration (Fig. 2, right) enabled us to calculate the 
affinity constant [KA = (7.8 ± 0.1) × 10
4 M-1] and the relaxivity of 
the adduct (r1
b = 38.7 ± 0.1 mM-1 s-1). This r1 value is 4.4 times 25 
higher than that measured for the isolated complex and clearly 
reflects the slowing down of molecular tumbling as indicated by 
the presence in the 1H NMRD profile of a narrow peak centred 
around 30 MHz (Figure 2). However, unlike many of the cases 
reported in the literature, the slowing down of rotational motion 30 
results in a large increase of r1 because the limiting effect of the 
slow water exchange does not occur. This is the main advantage 
of the propionamide group: apart from minor effects on the 
thermodynamic stability, the leveling effect of the long M is 
lifted and high relaxivity values can be attained. Similarly, a large 35 
relaxation enhancement has been recently observed by M. F. 
Ferreira et al. for the binding to HSA of the Gd(III) complex with 
the related DO3A-N-(α-pyrenebutanamido)propionate chelator.22 
Moreover, we observe that the r1 value surpasses those reported 
for other HSA-bound Gd(III) complexes with q = 1 and bearing a 40 
cholic acid residue.27, 49 In particular, a recent work has shown 
that the GdAAZTA-cholic acid system decreases its hydration 
state (from 2 to 1) upon interaction with the protein and the r1 of 
the host-guest adduct is only 29.0 mM-1s-1 (20 MHz, 298 K). In 
the same report, an r1 value of 26.8 mM
-1s-1 was measured for a q 45 
= 1 GdDTPA-like chelate bearing the same cholic acid residue, 
under analogous experimental conditions. The analysis of the 
NMRD profile requires the use of the model-free Lipari-Szabo 
approach incorporated into the SBM equations for the IS 
relaxation mechanism.50, 51 This model allows to take into 50 
account the contribution of a faster local motion (τRL) of the 
coordination cage about the binding group superimposed to the 
overall global rotation of the paramagnetic supramolecular adduct 
(τRG). The correlation of the two types of motions is described by 
the parameter S2 whose value may vary between zero (completely 55 
independent motions) and one (totally correlated motions). The 
best-fit parameters, reported in Table 5, indicate a relatively 
restricted degree of internal rotation of GdL5 about the 
deoxycholic group at the binding site. At the same, it is clear that 
at the imaging fields (1.5 – 3 T) the relaxivity is dominated by the 60 
local rotational dynamics (τRL and S
2) rather than by the exchange 
of the bound water molecule.  
Conclusions 
The introduction of an additional methylene group into an 
acetamide arm in DOTA-monoamide derivatives has a 65 
pronounced impact on the water exchange dynamics of the 
corresponding, neutral Gd(III) complexes. The value of kex 
increases by ca. two orders of magnitude and this implies that the 
limiting effect on the relaxivity by a slow rate of water exchange 
is removed when GdDOTAMAP chelates are conjugated to 70 
macromolecules or nanosized scaffolds. This is further 
demonstrated by the new cholic acid GdDOTAMAP derivative 
that shows a high affinity for HSA, giving rise  to a 
supramolecular adduct whose relaxivity, 38.7 mM-1 s-1 at 20 MHz 
and 298 K, is in the upper range of values for q = 1 Gd-chelates. 75 
The thermodynamic and kinetic data in aqueous solution outline 
that the replacement of an acetamide arm with a propionamide 
moiety only results in a negligible decrease of logKGdL 
(1<logK<2). From the point of view of the kinetic inertness, the 
effects are more pronounced, as shown by the t1/2 values for the 80 
dissociation of GdL that decreases by three order of magnitude 
passing from the acetamide (GdL1) to the propionamide (GdL2) 
coordination. Nevertheless, GdL2 is significantly more inert than 
established Gd-chelates such as GdDTPA oe GdDO3A.  
In general, neutral macrocyclic complexes of lanthanide(III) 85 
cations present several advantages as imaging probes in 
preclinical studies. GdDOTAMAP appears particularly 
interesting as MRI contrast agent since it combines favourable 
properties in terms of stability and inertness with the occurrence 
of a fast exchange regime for the bound water molecule that 90 
allows the achievement of large relaxivity enhancements. 
Experimental 
All chemicals were purchased from Sigma-Aldrich or Alfa Aesar 
unless otherwise stated and were used without further 
purification. Ligands L1 and L2 were synthesized as reported in 95 
the literature.19,52 1H and 13C NMR spectra were recorded on 
Bruker Avance III spectrometer operating at 11.74 T. Chemical 
shifts are reported relative to TMS and were referenced using the 
residual proton solvent resonances. Electrospray ionization mass 
spectra (ESI MS) were recorded on a SQD 3100 Mass Detector 100 
(Waters), operating in positive or negative ion mode, with 1% v/v 
formic acid in methanol as the carrier solvent. 
 
Synthesis of Benzyl 2-(acrylamido)acetate. A solution of 
acryloyl chloride (300 µL; 3.67 mmol) in dry CH2Cl2 (5 mL) was 105 
slowly added at 0°C to a suspension of benzyl glycinate (1,03 g; 
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6,23 mmol) and K2CO3 (1,5 g; 11.01 mmol) in dry CH2Cl2 (15 
mL) under N2 atmosphere. The reaction mixture was stirred for 1 
h at RT and then evaporated in vacuo. The resulting oil was 
dissolved in CH2Cl2 (10 mL), washed with HCl 0.1 M (5 mL) and 
H2O for three times and dried with Na2SO4. The organic solution 5 
was then filtered and evaporated under reduced pressure to obtain 
the product (439 mg, 2.00 mmol, yield 55%). 1H NMR (400 
MHz, CDCl3): 4.14 (s, 2H, NHCH2CO), 5.18 (s, 2H, CH2 
benzyl); 5,64 - 5.67 (m, 2H, CH2=CH); 6.11 – 6.37 (m, 1H, 
CH2=CH); 7.33 – 7.35 (m, 5H, CH phenyl) ppm.
 13C NMR (400 10 
MHz, CDCl3): 41.53 (NHCH2CO), 67.38 (CH2 benzyl); 127.41 
(CH2=CH); 128.27 (CH phenyl); 130.19 (CH2=CH); 135.18 (C 
phenyl), 165.71 (CONHCH2) 169.98 (COOBn) ppm. ESI-MS
+ 
calculated for C12H14NO3 [M+H]
+: 220,24; found: 220.12. 
 15 
Synthesis of DOTAMAP-Gly-Bn (1): A solution of 
DO3A(tBu)3 (0.1 g; 0.19 mmol), DIPEA (99 µL; 0.57 mmol) and 
benzyl 2-(acrylamido)acetate (83 mg; 0.38 mmol) in CH3CN (5 
mL) was refluxed overnight. The crude product was purified by 
silica gel chromatography (95:5 DCM/methanol) to afford 3 (55 20 
mg, 0.076 mmol, yield 40%). 1H NMR (400 MHz, CDCl3): 1.42 
(s, 27H, CH3); 2.66-2.74 (m, 2H, NCH2CH2CO); 3.05-3.26 (m, 
16H, CH2 ring); 3.28-3.30 (m, 2H, NCH2CH2CO); 3.36 (s, 6H, 
NCH2CO); 4.66 (s, 2H, NHCH2CO), 5.23 (s, 2H, CH2 benzyl); 
7.25 – 7.34 (m, 5H, CH phenyl) ppm. 13C NMR (400 MHz, 25 
CDCl3): 28.25 (C(CH3)3); 29.75 (NCH2CH2CO); 43.31 
(NHCH2CO); 48.31 (NCH2CH2CO); 52.10-52.21 (CH2 ring); 
61,2 (NCH2CO); 65.23 (CH2 benzyl); 81.24 (C(CH3)3); 127.76 
(CH phenyl); 141.18 (C phenyl), 166.98 (CONHCH2); 170.88 
(COOBn); 171,2 (COC(CH3)3) ppm. ESI-MS
+ calculated for 30 
C38H64N5O9 [M+H]
+: 734.93; found: 735.04. 
 
Synthesis of DOTAMAP-Gly (2): Pd/C (10% w/w, 73 mg) was 
added to the solution of 1 (730 mg, 1 mmol) in MeOH (15 mL) 
and the reaction was stirred under H2 for 2 days at RT. Then, the 35 
solution was filtered on celite and dried under reduced pressure to 
obtain 2 (643 mg, 1 mmol, quantitative yield). 1H NMR (400 
MHz, CDCl3): 1.38 (s, 27H, C(CH3)3); 2.70-2.73 (m, 2H, 
NCH2CH2CO); 3.01-3.35 (m, 16H, CH2 ring); 3.31-3.36 (m, 2H, 
NCH2CH2CO); 3.43 (s, 6H, NCH2CO); 4.71 (s, 2H, 40 
NHCH2COOH) ppm. 
13C NMR (400 MHz, CDCl3): 28.38 
(C(CH3)3); 31.41 (NCH2CH2CO); 45.21 (NHCH2CO); 49.02 
(NCH2CH2CO); 52.01-52.74 (CH2 ring); 60,1 (NCH2CO); 81.75 
(C(CH3)3); 166.98 (CONHCH2); 170,8 (COC(CH3)3); 173.25 
(COOH). ESI-MS+ calculated for C31H58N5O9 [M+H]
+: 644,81; 45 
found: 645.12. 
 
Synthesis of DOTAMAP-Gly-cholic acid methyl ester (3). 
Compound 2 (302 mg, 0.47 mmol) was dissolved in DMF (20 
mL), then HATU (535 mg, 1.41 mmol) and DIPEA (163 µL, 0.94 50 
mmol) were added. Then, (3,5,12)-3-Amino-12-
hydroxycholan-24-oic acid methyl ester (198 mg, 0.47 mmol) 
dissolved in DMF (3 mL) was added. The reaction was attired at 
RT overnight. The mixture was evaporated in vacuo and the 
crude product was washed with H2O (3 x 5 mL) and then purified 55 
by silica gel chromatography (95:5 CH2Cl2/MeOH) to afford 3 
(162 mg, 0.16 mmol, yield 33%). 13C NMR (400 MHz, CDCl3): 
12.76 (CH3), 17.36 (CH3), 23.58 (CH2), 23.90 (CH3), 25.87 
(CH2), 26.68 (CH2), 27.41 (CH2), 28.10 (C(CH3)3), 28.90 (CH2), 
29.09 (CH2), 29.31 (CH2), 30.90 (CH2), 31.06 (CH2), 32.90 60 
(NCH2CH2CO), 33.12 (CH), 34.62 (CCH3), 35.07 (CH2), 35.84 
(CH), 36.58 (CH), 37.65 (CH), 44.98 (CH), 46.00 (NHCH2CO); 
46.54 (CH), 46.83 (CCH3), 48.30 (CHNH), 49.17 
(NCH2CH2CO), 52.0-53.1 (CH2 ring), 61.80 (NCH2COtBu), 
74.65 (CHOH), 81.91 (C(CH3)3), 164.78 (CONHCH2), 167.41 65 
(CONH), 169.50 (COC(CH3)3) ppm. ESI-MS
+ calculated for 
C56H99N6O12 [M+H]
+: 1048,41; found: 1048.50. 
 
Synthesis of DOTAMAP-gly-cholic acid (L5). the protected 
ligand 3 (160 mg, 0.15 mmol) was reacted overnight at RT with 70 
LiOH (10.8 mg, 0.45 mmol) in THF (5 mL). The solution was 
then dried under reduced pressure and the product was dissolved 
in CH2Cl2 and washed thrice with H2O (5 mL). The organic 
solution was then dried with Na2SO4, filtered and evaporated 
under reduced pressure to obtain the intermediate that was further 75 
reacted by dissolving it in DCM:TFA (1:1 v/v 2mL : 2mL). The 
mixture was stirred overnight at RT. After evaporation in vacuo, 
Et2O was added and the precipitate formed was washed twice 
with Et2O to obtain the ligand L5 as hydrated trifluoacetate salt 
(150 mg, 0.134 mmol, 90% yield).13C NMR (400 MHz, D2O): 80 
12.66 (CH3), 16.87 (CH3), 23.43 (CH2), 23.95 (CH3), 24.20 
(CH2), 25.33 (CH2), 26.12 (CH2), 28.75 (CH2), 29.13 (CH2), 
30.16 (CH2), 30.96 (CH2), 31.15 (CH2), 32.90 (NCH2CH2CO), 
33.18 (CH), 34.38 (CCH3), 35.53 (CH2), 35.94 (CH), 37.68 (CH), 
41.51 (CH), 46.46 (NHCH2CO), 46.71 (CH), 48.10 (CH), 49.03 85 
(CCH3), 49.14 (CHNH), 49.95 (NCH2CH2CO), 50.0-53.0 (CH2 
ring), 60.22 (NCH2COOH), 73.19 (CHOH), 170.13 (CONH), 
172.30 (CONHCH2),  173.49 (COOH), 178.80 (COOH, 
deoxycholic acid) ppm. ESI-MS+ calculated for C43H73N6O12 
[M+H]+: 866,06; found: 866.20. CHN: calculated for 90 
C43H72N6O12·2CF3COOH·3H2O: C, 49.90; H, 7.13; N, 7.43; 
found: C, 48.96; H, 7.35; N, 7.78. 
Equilibrium measurements: The chemicals used for the 
experiments were of analytical grade. The LnCl3 solutions were 
prepared from LnCl3·xH2O (x=5-7) (Aldrich; 99.9%). The 95 
concentration of the LnCl3 solutions were determined by 
complexometric titration with standardized Na2H2edta and 
xylenol orange as indicator. The concentration and the 
protonation constants of H3L1 and H3L2 was determined by pH-
potentiometric titration in the presence and absence of a large 100 
(40-fold) excess of CaCl2 ([L]=0.002 M). The pH-potentiometric 
titrations were made with standardized 0.2 M KOH. The stability 
constants of the Ln(III)-complexes with L1 and L2 were 
determined using the “out-of-cell” technique because of the slow 
formation reactions. The pH range and the time needed to reach 105 
the equilibria were determined by spectrophotometry for the 
formation of CeL1 and CeL2 (the UV absorption band of the 
Ce(III) resulting from the 4f – 5d transition is very sensitive for 
complex formation). Eight samples for each Ln(III) complexes of 
L1 and L2 were prepared in the range of 2.5 - 4.0 110 
([Ln3+]=[L]=0.002 M). The samples were kept at 298 K for 12 
weeks to reach the equilibrium. For the calculations of the 
stability constants of the LnL1 and LnL2, the protonation 
constants of the Ln(III)-complexes were also used, which were 
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calculated from the pH-potentiometric titration curve of the LnL1 
and LnL2 complexes in the pH range of 1.7 – 11.7.  For the pH 
measurements and titration, a Metrohm 785 DMP Titrino titration 
workstation and a Metrohm-6.0233.100 combined electrode were 
used. Equilibrium measurements were carried out at a constant 5 
ionic strength (0.1M KCl) in 6 mL samples at 298 K. The 
solutions were stirred and N2 was bubbled into them. The 
titrations were made in the pH range of 1.7-11.7. For the 
calibration of the pH meter, KH-phthalate (pH=4.005) and borax 
(pH=9.177) buffers were used. For the calculation of [H+] from 10 
the measured pH values, the method proposed by Irving et al. 
was used.53 A 0.01M HCl solution was titrated with the 
standardized KOH solution in the presence of 0.1 M KCl ionic 
strength. The differences between the measured (pHread) and 
calculated pH (-log[H+]) values were used to obtain the  15 
equilibrium H+ concentration from the pH values, measured in 
the titration experiments. The ionic product of water was found to 
be logKw=13.85, which was calculated from the pH potentiomtric 
data of 0.01M HCl solution titrated with the standardized KOH 
solution at 25C in 0.1 M KCl in the pH range 10.5 – 11.7. The 20 
stability constant of CeL1 was determined by spectrophotometry 
looking at the absorption bands of Ce(III)-complexes in the 
wavelength range of 220-345 nm. Eight samples of Ce3+-L1 were 
prepared in the range of 2.5 - 4.2 ([Ce3+]=[L]=0.0015 M). The pH 
of the sample were adjusted by stepwise addition of a solution of 25 
KOH and HCl . The ionic strength of solutions was maintained 
by 0.1 M KCl. The samples were kept at 298 K for 12 weeks. The 
absorbance values of the samples were determined at 10 
wavelengths (304, 308, 312, 316, 320, 324, 328, 332, 336 és 340 
nm) on the absorption band of Ce(HL1). For the calculations of 30 
the stability constants of the CeL1, the molar absorbancies of the 
Ce3+ and Ce(HL1) were determined by recording the spectra of 
1.010-3, 2.010-3 and 310-3 M solutions of Ce3+ and Ce(HL1) 
(pH=6.0, 0.1 M KCl, 25 C). The protonation constant of the 
CeL1 was also determined by pH-potentiometric titrations of 35 
CeL1 in the pH range of 1.7 – 11.7 ([CeL1]=0.002 M). The 
spectrophotometric experiments were performed with Cary 1E 
spectrophotometer and 1 cm quartz cuvette at 298 K. The 
protonation and stability constants were calculated with the 
PSEQUAD program.54 40 
Kinetic studies: Formation rates of Ce(III)- and Eu(III)-
complexes of L1 and L2 were determined by spectrophotometry 
at 320 and 255 nm, respectively, and in the pH range about 3.7 - 
6.0. The concentration of the ligands was 210-4 M. The 
formation of Ln(III)-complexes was studied in the presence of a 5 45 
to 50 fold Ln3+ excess in order to keep the pseudo-first-order 
conditions. The pseudo-first-order rate constants (kobs) were 
calculated by fitting the absorbance values to the Eqn. (5): 
                                                   (5) 
where A0, Ae and At are the absorbance values at the start, at 50 
equilibrium and at the time t of the reaction. The temperature was 
maintained at 298 K and the ionic strength of the solutions was 
kept constant (0.1 M KCl). In order to keep the pH values 
constant, 1,4-dimethylpiperazine (pH range 3.2 - 4.1), N-
methylpiperazine (pH range 4.1 - 5.2) and piperazine (pH range 55 
4.7 - 6.6) buffers (0.01 M) were used.   
The kinetic inertness of GdL1 and GdL2 was characterized by 
the rates of the dissociation reactions taking place in 0.05 – 1.0 M 
[HCl] solution. The dissociation reactions of GdL1 and GdL2 
were followed by measuring the longitudinal relaxation time of 60 
H2O protons (T1) with a Bruker MQ20 Minispec spectrometer at 
20 MHz. The temperature of the sample holder was controlled 
with a thermostated air stream. The longitudinal relaxation time 
was measured with the “inversion recovery” method (180 -  - 
90) by using 8 different  values. The measurements were 65 
performed with 1 mM solution of the GdL1 and GdL2 
complexes, so the relaxation rate values were given as r1=1/T1p + 
1/T1w where T1p and T1w were the relaxation time of water protons 
in the presence and absence of Gd(III) complexes. The pseudo-
first-order rate constants (kd) were calculated by fitting the 70 
relaxation rate (1/T1p) data to Eqn. (6).  
                                                        (6) 
where rr, rt and rv are the relaxivity values of reactants (Gd(HL1): 
r1p= 4.6 mM
-1s-1, Gd(HL2): r1p= 4.9 mM
-1s-1, 20 MHz, 25C),19 
the product (Gd3+: r1p= 13.1 mM
-1s-1, 20 MHz, 25 C)  and at the 75 
time t of the reaction. The temperature was maintained at 298 K 
and the ionic strength of the solutions was kept constant 
([HCl]+[KCl]=1.0 M). The calculation of the kinetic parameters 
were performed by the fitting of the absorbance - time and 
relaxation rate – time data pairs with the Micromath Scientist 80 
computer program (version 2.0, Salt Lake City, UT, USA).55 
Relaxometric measurements: The water proton longitudinal 
relaxation rates as a function of the magnetic field strength were 
measured in non-deuterated aqueous solutions on a fast field-
cycling Stelar SmarTracer relaxometer (Stelar s.r.l., Mede (PV), 85 
Italy) over a continuum of magnetic field strengths from 0.00024 
to 0.25 T (corresponding to 0.01-10 MHz proton Larmor 
frequencies). The relaxometer operates under computer control 
with an absolute uncertainty in 1/T1 of ± 1%. Additional 
longitudinal relaxation data in the range 15-70 MHz were 90 
obtained on a Stelar Relaxometer connected to a Bruker WP80 
NMR electromagnet adapted to variable-field measurements (15-
80 MHz proton Larmor frequency). The exact concentration of 
GdIII was determined by measurement of bulk magnetic 
susceptibility shifts of a tBuOH signal or by inductively coupled 95 
plasma mass spectrometry (ICP-MS, Element-2, Thermo-
Finnigan, Rodano (MI), Italy). The 1H T1 relaxation times were 
acquired by the standard inversion recovery method with typical 
90° pulse width of 3.5 s, 16 experiments of 4 scans. The 
temperature was controlled with a Stelar VTC-91 airflow heater 100 
equipped with a calibrated copper–constantan thermocouple 
(uncertainty of ±0.1 °C).The non-covalent interaction of GdL5 
with HSA was evaluated by using the Proton Relaxation 
Enhancement (PRE) method: R1 was monitored as a function of 
e
)tk(
e0t Ae)AA(A
obs  
v
)tk(
vrt re)rr(r
d  
Page 9 of 12 Dalton Transactions
D
al
to
n
Tr
an
sa
ct
io
ns
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
03
 F
eb
ru
ar
y 
20
15
. D
ow
nl
oa
de
d 
by
 S
el
cu
k 
U
ni
ve
rs
ity
 o
n 
04
/0
2/
20
15
 0
1:
19
:2
4.
 
View Article Online
DOI: 10.1039/C4DT03939D
 10  |  Journal Name, [year], [vol], 00–00 This journal is © The Royal Society of Chemistry [year] 
the amount of HSA added to 0.1 mM GdL5 solution, at 298 K 
and 20 MHz, while maintaining the pH at 6-7. 
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while possessing a rate of water exchange two orders of magnitude greater than GdDOTA 
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